Company

Bright Minds Biosciences

As of the edition of 20 October 2026, Bright Minds Biosciences runs 1 drug.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Total1

Where its trials are

  • Inherited and neonatal: 2 trials led
  • Nervous system: 2 trials led
  • Nutrition and metabolism: 1 trials led